Literature DB >> 24492357

Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United States.

W Dong1, S Chochua, L McGee, D Jackson, K P Klugman, J E Vidal.   

Abstract

Three invasive Streptococcus pneumoniae strains nonsusceptible to linezolid were isolated in the United States between 2001 and 2012 from the CDC's Active Bacterial Core surveillance. Linezolid binds ribosomal proteins where structural changes within its target site may confer resistance. Our study identified mutations and deletions near the linezolid binding pocket of two of these strains within the rplD gene, which encodes ribosomal protein L4. Mutations in the 23S rRNA alleles or the rplV gene were not detected.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24492357      PMCID: PMC4023712          DOI: 10.1128/AAC.02630-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.

Authors:  Nicole Wolter; Anthony M Smith; David J Farrell; William Schaffner; Matthew Moore; Cynthia G Whitney; James H Jorgensen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Authors:  Silke Besier; Albrecht Ludwig; Johannes Zander; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

3.  In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program.

Authors:  Deborah C Draghi; Daniel J Sheehan; Patricia Hogan; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  IS21-558 insertion sequences are involved in the mobility of the multiresistance gene cfr.

Authors:  Corinna Kehrenberg; Frank M Aarestrup; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

5.  Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 6.  Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.

Authors:  K P Klugman; D E Low; J Metlay; J-C Pechere; K Weiss
Journal:  Int J Antimicrob Agents       Date:  2004-11       Impact factor: 5.283

7.  LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).

Authors:  Ronald N Jones; Thomas R Fritsche; Helio S Sader; James E Ross
Journal:  Diagn Microbiol Infect Dis       Date:  2007-08-27       Impact factor: 2.803

8.  Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.

Authors:  Seok-Ming Toh; Liqun Xiong; Cesar A Arias; Maria V Villegas; Karen Lolans; John Quinn; Alexander S Mankin
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

9.  First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Mariana Castanheira; Joseph DiPersio; Michael A Saubolle; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

10.  Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center.

Authors:  Keith Miller; Colin J Dunsmore; Colin W G Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

View more
  9 in total

1.  Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).

Authors:  Michael A Pfaller; Rodrigo E Mendes; Jennifer M Streit; Patricia A Hogan; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.

Authors:  Paulina A Hawkins; Sopio Chochua; Delois Jackson; Bernard Beall; Lesley McGee
Journal:  Microb Drug Resist       Date:  2014-08-12       Impact factor: 3.431

Review 3.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Tedizolid Phosphate: a Next-Generation Oxazolidinone.

Authors:  Jeffrey M Rybak; Karrine Roberts
Journal:  Infect Dis Ther       Date:  2015-02-24

Review 5.  Antimicrobial resistance mechanisms and potential synthetic treatments.

Authors:  Junaid Ali; Qasim A Rafiq; Elizabeth Ratcliffe
Journal:  Future Sci OA       Date:  2018-02-05

6.  In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China.

Authors:  Xia Yu; Fengmin Huo; Fen Wang; Shu'an Wen; Guanglu Jiang; Yi Xue; Lingling Dong; Liping Zhao; Rui Zhu; Hairong Huang
Journal:  Infect Drug Resist       Date:  2021-11-09       Impact factor: 4.003

7.  220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms.

Authors:  Sharmila J Talekar; Sopio Chochua; Katie Nelson; Keith P Klugman; Cassandra L Quave; Jorge E Vidal
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

8.  A Mechanism of Unidirectional Transformation, Leading to Antibiotic Resistance, Occurs within Nasopharyngeal Pneumococcal Biofilm Consortia.

Authors:  Santiago M Lattar; Xueqing Wu; Jennifer Brophy; Fuminori Sakai; Keith P Klugman; Jorge E Vidal
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

9.  Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.

Authors:  Kate E Wardenburg; Robert F Potter; Alaric W D'Souza; Tahir Hussain; Meghan A Wallace; Saadia Andleeb; Carey-Ann D Burnham; Gautam Dantas
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.